Coherus BioSciences Inc. News
Regeneron's Eylea Win Leaves an Elephant in the Room
Regeneron's Eylea eye-disorder drug faces competitive pressure on multiple fronts. New data could cement its dominance.
Biosimilars Are Saving America $1 Billion Per Month
Competitive drug prices are great for consumers. Turns out, they're good for industry, too.
Can This Small-Cap Biotech 5x Revenue by 2026?
It has one product on the market and up to four more launching by the end of 2023. The growth trajectory depends on execution.
FDA Approves Coherus' Version of Abbvie's Humira, Best-Selling Drug in the U.S.
Coherus was cleared by the FDA for a drug that's similar to AbbVie's Humira. Coherus plans to launch the psoriasis treatment in July 2023.
Five Below, Splunk, Snap: 'Mad Money' Lightning Round
Jim Cramer weighs in on Five Below, Splunk, Snap, Crown Castle, Square, 3D Systems, Dana, Alibaba, Coherus Biosciences.
The One-and-Wait Plan: Cramer's 'Mad Money' Recap
Jim Cramer's got a plan: Fed Chairman Jay Powell should hike once, then wait -- and maintain the independence of the Fed.
Five Rules For This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)
Even with Monday's sharp reversal, Jim Cramer says he still likes this market.
Biotech Movers: Acceleron, Clovis, Coherus
Acceleron Pharma, Clovis Oncology and Coherus BioSciences premarket trading on Tuesday.
Biotech Movers: Coherus, XBiotech, Flexion
Coherus BioSciences, XBiotech and Flexion Therapeutics were among the biotech stock movers in premarket trading on Monday.
AbbVie Stock Lower on Humira Patent Ruling
The drug is responsible for more than 60% of AbbVie's top line.
Breaking News
Illumina's Singapore Tax Holiday is About to Expire
The DNA sequencing giant generated over 10% of its diluted earnings per share in 2021 from a tax holiday.
Oil Volatility Returns, Pushing Gasoline Prices Higher
The 14-week decline in gasoline prices ended while two million people in Florida are still without power.
New Electric Vehicle Beats Tesla When it Comes to the Environment
A new EV would radically change how cars are made and that could be a threat to the market leader.
McDonald's Menu Adds a (Very) New Take on an Old Favorite
The fast-food giant has been hesitant to make changes like this, but Wendy's bold move may have forced it to.